Biotechnology March 17, 2025 Latigo Collects $150M to Get Non-Opioid Data to Compete with Vertex in Acute Pain
Biotechnology March 3, 2025 Perfuse Therapeutics Announces Positive Visual, Structural and Safety Data from a Ph1/2a Trial of PER-001 in Glaucoma Patients at the American Glaucoma Society Meeting
Biotechnology October 11, 2024 Upstream Swells IPO to $255M as it Prepares to Join Nasdaq Along with CAMP4
